These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4815860)

  • 1. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.
    Judd HL; Lucas WE; Yen SS
    Am J Obstet Gynecol; 1974 Mar; 118(6):793-8. PubMed ID: 4815860
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma.
    Vesterinen E; Backas NE; Pesonen K; Stenman UH; Laatikainen T
    Arch Gynecol; 1981; 230(3):205-11. PubMed ID: 6787991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol, androstenedione, testosterone, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer.
    Bremond AG; Claustrat B; Rudigoz RC; Seffert P; Corniau J
    Gynecol Oncol; 1982 Aug; 14(1):119-24. PubMed ID: 6212296
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal profile following total abdominal hysterectomy and bilateral salpingo-oophorectomy in post-menopausal endometrial carcinoma.
    Marchesoni D; Gangemi M; Maggino T; Paternoster D; Mozzanega B; Sormani-Zodo F; Vincenti E
    Clin Exp Obstet Gynecol; 1982; 9(4):238-42. PubMed ID: 7168898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone androstenedione testosterone and clinical characteristics in endometrial carcinoma.
    Boman K; Bäckström T; Gerdes U; Stendahl U
    Anticancer Res; 1991; 11(6):2163-6. PubMed ID: 1776856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androstenedione metabolism in patients with endometrial cancer.
    Calanog A; Sall S; Gordon GG; Southren AL
    Am J Obstet Gynecol; 1977 Nov; 129(5):553-6. PubMed ID: 910844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aging and delta 4-androstenedione and testosterone production in the ovary].
    Nagasako S
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1945-54. PubMed ID: 6663127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone metabolism in endometrial cancer.
    Calanog A; Sall S; Gordon GG; Olivo J; Southren AL
    Am J Obstet Gynecol; 1976 Jan; 124(1):60-3. PubMed ID: 1244748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer.
    Reed MJ; Hutton JD; Baxendale PM; James VH; Jacobs HS; Fisher RP
    J Steroid Biochem; 1979 Jul; 11(1C):905-11. PubMed ID: 491651
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
    Scirpa P; Mango D; Battaglia F; Scirpa S; Montemurro A
    Maturitas; 1982 Apr; 4(1):33-42. PubMed ID: 7099001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.
    Judd HL; Judd GE; Lucas WE; Yen SS
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1020-4. PubMed ID: 4430702
    [No Abstract]   [Full Text] [Related]  

  • 12. Oestrogen excretion and ovarian pathology in postmenopausal women with atypical hyperplasia, adenocarcinoma and mixed adenosquamous carcinoma of the endometrium.
    Rome M; Brown JB; Mason T; Smith MA; Laverty C; Fortune D
    Br J Obstet Gynaecol; 1977 Feb; 84(2):88-97. PubMed ID: 843487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone acetate release from silastic devices as replacement for local irradiation by radium tubes in preoperative intrauterine packing for endometrial adenocarcinoma: a preliminary study.
    Decoster JM; Bonte J; Marcq A
    Gynecol Oncol; 1977 Jun; 5(2):189-95. PubMed ID: 881131
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian and peripheral androgen and oestrogen levels in post-menopausal women: correlations with ovarian histology.
    Lucisano A; Russo N; Acampora MG; Fabiano A; Fattibene M; Parlati E; Maniccia E; Dell'Acqua S
    Maturitas; 1986 Mar; 8(1):57-65. PubMed ID: 3702762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
    Nagamani M; Hannigan EV; Dillard EA; Van Dinh T
    J Clin Endocrinol Metab; 1986 Mar; 62(3):508-12. PubMed ID: 3944235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of progestogens as an adjuvant to surgery in the treatment of stage I adenocarcinoma of the uterine corpus.
    Moazzami B; Van der Walt JD; Boyd NR
    Br J Obstet Gynaecol; 1983 Feb; 90(2):178-81. PubMed ID: 6218817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal profile of endometrial cancer.
    Oettinger M; Samberg I; Levitan Z; Eibschitz I; Sharf M
    Gynecol Obstet Invest; 1984; 17(5):225-35. PubMed ID: 6735271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma hormone profiles after the menopause and bilateral oöphorectomy.
    Studd JW; Chakravarti S; Collins WP
    Postgrad Med J; 1978; 54 Suppl 2():25-30. PubMed ID: 740577
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma hormone levels and the conversion of androstenedione to oestrone in women with endometrial cancer [proceedings].
    Reed MJ; Hutton JD; Baxendale PM; Goodall AB; Fern M; James VH; Jacobs HS; Fisher PR
    J Endocrinol; 1978 Nov; 79(2):54P-55P. PubMed ID: 731174
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.